From April 23 to 25, 2024, Ananta Medicare took part in the scientific event “National Therapeutic Congress with International Participation – AIM 2025.”

The congress brought together physicians from various therapeutic disciplines, who today face a broad and growing set of responsibilities in patient management.

During the congress, leading experts from diverse fields of medical science covered the following key areas:

-  Advanced strategies for managing patients with cardiovascular diseases.

- Management of liver and gallbladder disorders: from guidelines to clinical practice.

- Innovative diagnostic methods in the practice of internal medicine physicians.

- Kidney and urinary tract diseases in therapeutic care.

            Special attention was given to modern approaches to the diagnosis, treatment, and prevention of urological diseases, which remain highly prevalent today. Contributing factors include environmental issues, poor dietary habits, physical inactivity, and chronic stress.

One of the most common urological conditions discussed was urolithiasis (kidney stone disease) — a condition characterized by the formation of stones in the urinary system.

Urolithiasis carries significant social and clinical relevance, with around 55% of patients reporting serious quality of life impairments, particularly during acute episodes. Furthermore, it is a recurrent disease, making preventive strategies essential.

Effective management of urolithiasis remains a critical challenge in modern medicine.

A keynote presentation on current principles of urolithiasis prevention was delivered by Professor Dmytro Volodymyrovych Shchukin, MD. He highlighted the pivotal role of dietary interventions in preventing stone formation and paid special attention to the clinical potential of Nokamen^®, a modern complex remedy used in urolithiasis care.

Nokamen^® is a plant-mineral complex containing ingredients with multiple beneficial properties, including litholytic, anti-inflammatory, antioxidant, nephroprotective effects, etc. Thanks to its thoughtfully selected combination of herbal ingredients, Nokamen^® offers a broad pharmacological profile for managing inflammatory conditions of the urinary tract and serves as an ideal option for the prevention of urolithiasis.

NOKAMEN^® — A Nephroprotective Formula with Broad Capabilities*.  

Food supplement. Not a medicinal product. For full product information, please refer to the package leaflet.